Skip to content
SEC filings edition: Wednesday, November 18, 2026 · 275 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Friday, November 20, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 18, 2026 0bankruptcies 5delisting notices 2late filings 33leadership changes 0IPO filings 177private raises 25earnings releases
Company page · CIK 1783036 · NCEL

NewcelX Ltd.

Filing with the SEC Foreign private issuer Zurich Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Net loss in 2025Net loss of $8.3M for the year (2024: −$7.2M).
  • Private capital raiseOn Nov 18, 2026 the company filed Form D: $2.9M offered · $2.9M sold · Biotechnology. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$8.3M−$7.2M
Total assets$11.4M$903K
Total liabilities$4.2M$8.9M
Stockholders’ equity$7.3M−$8M
Cash and equivalents$2.2M$650K

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
NewcelX Ltd.
Formerly: NLS Pharmaceutics Ltd.
CIK
0001783036
Tickers
NCEL
Kind of filer
Foreign private issuer
Non-accelerated filer; Emerging growth company
Legal form
Other
Status
Filing with the SEC
State of incorporation
Switzerland
Business address
Zurich (outside the US)
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
20-F for the period ended Dec 31, 2025
Last quarterly report
—
Latest exempt offering
$2.9M offered · $2.9M sold
Revenue range stated: Decline to Disclose
Bankruptcy reported
Not in our data
Last edition event
Nov 18, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Private raise (Form D): $2.9M offered · $2.9M sold · Biotechnology
    Form D · items 06B · filed Nov 18, 2026 · filing · edition of Nov 18, 2026
  • Private raise (Form D)
    Form D · items 06b · filed Aug 24, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed May 13, 2026 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed May 4, 2026 · filing
  • Annual report (20-F): 20-F for the period ended Dec 31, 2025
    Form 20-F · filed Apr 29, 2026 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Nov 14, 2025 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Nov 13, 2025 · filing
  • IPO registration filed: Registration statement (F-1)
    Form F-1 · filed Sep 25, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jul 10, 2025 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Jun 24, 2025 · filing
  • Annual report (20-F): 20-F for the period ended Dec 31, 2024
    Form 20-F · filed May 16, 2025 · filing
  • Late annual report notice: Annual report (20-F) will be late
    Form NT 20-F · filed May 1, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Apr 14, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jan 22, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Oct 21, 2024 · filing
  • IPO registration filed: Registration statement (F-1)
    Form F-1 · filed Aug 27, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jul 15, 2024 · filing
  • IPO registration filed: Registration statement (F-1)
    Form F-1 · filed May 30, 2024 · filing
  • Annual report (20-F): 20-F for the period ended Dec 31, 2023
    Form 20-F · filed May 15, 2024 · filing
  • Late annual report notice: Annual report (20-F) will be late
    Form NT 20-F · filed Apr 30, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Apr 3, 2024 · filing
  • Annual report (20-F): 20-F for the period ended Dec 31, 2022
    Form 20-F · filed May 5, 2023 · filing
  • Late annual report notice: Annual report (20-F) will be late
    Form NT 20-F · filed May 1, 2023 · filing